Daehan New Pharm Co. Ltd Asset Resilience Ratio

Latest as of September 2025: 4.14%

Daehan New Pharm Co. Ltd asset resilience ratio. Daehan New Pharm Co. Ltd (054670) has an Asset Resilience Ratio of 4.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Daehan New Pharm Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩10.40 Billion

≈ $7.05 Million USD Cash + Short-term Investments

Total Assets

₩251.53 Billion

≈ $170.46 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Daehan New Pharm Co. Ltd (2014–2024)

Asset resilience ratio of Daehan New Pharm Co. Ltd from 2014 to 2024. This chart shows how Daehan New Pharm Co. Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Daehan New Pharm Co. Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Daehan New Pharm Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Daehan New Pharm Co. Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.40 Billion	4.14%
Total Liquid Assets	₩10.40 Billion	4.14%

Asset Resilience Insights

Limited Liquidity: Daehan New Pharm Co. Ltd maintains only 4.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Daehan New Pharm Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Daehan New Pharm Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Daehan New Pharm Co. Ltd Asset Resilience Ratio by Year (2014–2024)

Daehan New Pharm Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Daehan New Pharm Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	16.58%	₩36.70 Billion ≈ $24.87 Million	₩221.29 Billion ≈ $149.96 Million	+3.61pp
2023-12-31	12.98%	₩22.96 Billion ≈ $15.56 Million	₩176.93 Billion ≈ $119.90 Million	-3.88pp
2022-12-31	16.86%	₩28.55 Billion ≈ $19.35 Million	₩169.36 Billion ≈ $114.77 Million	+3.22pp
2021-12-31	13.63%	₩21.49 Billion ≈ $14.57 Million	₩157.64 Billion ≈ $106.83 Million	-1.66pp
2020-12-31	15.30%	₩20.36 Billion ≈ $13.80 Million	₩133.08 Billion ≈ $90.18 Million	+1.83pp
2019-12-31	13.47%	₩17.23 Billion ≈ $11.67 Million	₩127.91 Billion ≈ $86.68 Million	+5.95pp
2018-12-31	7.51%	₩8.17 Billion ≈ $5.54 Million	₩108.74 Billion ≈ $73.69 Million	+2.69pp
2017-12-31	4.83%	₩5.88 Billion ≈ $3.98 Million	₩121.82 Billion ≈ $82.55 Million	-2.97pp
2016-12-31	7.80%	₩10.19 Billion ≈ $6.91 Million	₩130.72 Billion ≈ $88.59 Million	+7.18pp
2015-12-31	0.61%	₩812.31 Million ≈ $550.49K	₩132.63 Billion ≈ $89.88 Million	-0.24pp
2014-12-31	0.86%	₩1.12 Billion ≈ $757.86K	₩130.47 Billion ≈ $88.42 Million	--

pp = percentage points

About Daehan New Pharm Co. Ltd

KQ:054670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$48.51 Million

₩71.58 Billion KRW

Market Cap Rank

#21828 Global

#1325 in Korea

Share Price

₩5100.00

Change (1 day)

-0.58%

52-Week Range

₩5090.00 - ₩7510.00

All Time High

₩21012.38